Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis® LCS. Established U.S. commercial and clinical infrastructure combined with Medicare reimbursem ...

The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,000 1 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

Swedish researchers published the results of the largest study ever conducted on AI-assisted mammography screening in The Lancet.

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather than annual mammograms, can lower the chance of more advanced cancers, ...

Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway ...